The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse

被引:95
作者
Bandapalli, Obul R. [1 ,2 ]
Schuessele, Stephanie [1 ,2 ]
Kunz, Joachim B. [1 ,2 ]
Rausch, Tobias [3 ]
Stutz, Adrian M. [3 ]
Tal, Noa
Geron, Ifat [4 ,5 ,6 ,7 ,8 ]
Gershman, Nava [4 ,5 ,6 ]
Izraeli, Shai [4 ,5 ,6 ]
Eilers, Juliane [1 ,2 ]
Vaezipour, Nina [2 ]
Kirschner-Schwabe, Renate [9 ]
Hof, Jana [9 ,10 ]
von Stackelberg, Arend [9 ]
Schrappe, Martin [11 ]
Stanulla, Martin [11 ,12 ]
Zimmermann, Martin [12 ]
Koehler, Rolf [13 ]
Avigad, Smadar [14 ]
Handgretinger, Rupert [15 ]
Frismantas, Viktoras [16 ]
Bourquin, Jean Pierre [16 ]
Bornhauser, Beat [16 ]
Korbel, Jan O. [3 ]
Muckenthaler, Martina U. [1 ,2 ]
Kulozik, Andreas E. [1 ,2 ]
机构
[1] Heidelberg Univ, Childrens Hosp, Dept Pediat Oncol Hematol & Immunol, D-69115 Heidelberg, Germany
[2] Heidelberg Univ, EMBL, Mol Med Partnership Unit, D-69115 Heidelberg, Germany
[3] EMBL, Genome Biol Unit, Heidelberg, Germany
[4] Sheba Med Ctr, Childhood Leukemia Res Inst, Tel Hashomer, Israel
[5] Sheba Med Ctr, Dept Pediat Hemato Oncol, Tel Hashomer, Israel
[6] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
[7] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA
[8] Univ Calif San Diego, Dept Med Stem Cell Program, San Diego, CA 92103 USA
[9] Charit Univ Med Berlin, Dept Pediat Oncol Hematol, Berlin, Germany
[10] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
[11] Univ Hosp Schleswig Holstein, Campus Kiel, Germany
[12] Hannover Med Sch, Dept Pediat Hematol Oncol, Hannover, Germany
[13] Heidelberg Univ, Dept Human Genet, D-69115 Heidelberg, Germany
[14] Schneider Childrens Med Ctr Israel, Felsenstein Med Res Ctr & Pediat Hematol Oncol, Petah Tiqwa, Israel
[15] Univ Tubingen Hosp, Childrens Hosp, Tubingen, Germany
[16] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland
关键词
STAT5B; mutation; pediatric T-ALL; OF-FUNCTION MUTATIONS; CONSTITUTIVE ACTIVATION; IL7R;
D O I
10.3324/haematol.2014.104992
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E188 / E192
页数:5
相关论文
共 15 条
  • [1] Constitutive activation of STAT5 by a point mutation in the SH2 domain
    Ariyoshi, K
    Nosaka, T
    Yamada, K
    Onishi, M
    Oka, Y
    Miyajima, A
    Kitamura, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) : 24407 - 24413
  • [2] Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia
    Atak, Zeynep Kalender
    Gianfelici, Valentina
    Hulselmans, Gert
    De Keersmaecker, Kim
    Devasia, Arun George
    Geerdens, Ellen
    Mentens, Nicole
    Chiaretti, Sabina
    Durinck, Kaat
    Uyttebroeck, Anne
    Vandenberghe, Peter
    Wlodarska, Iwona
    Cloos, Jacqueline
    Foa, Robin
    Speleman, Frank
    Cools, Jan
    Aerts, Stein
    [J]. PLOS GENETICS, 2013, 9 (12):
  • [3] NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia
    Bandapalli, Obul R.
    Zimmermann, Martin
    Kox, Corinne
    Stanulla, Martin
    Schrappe, Martin
    Ludwig, Wolf-Dieter
    Koehler, Rolf
    Muckenthaler, Martina U.
    Kulozik, Andreas E.
    [J]. HAEMATOLOGICA, 2013, 98 (06) : 928 - 936
  • [4] Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia
    Breit, Stephen
    Stanulla, Martin
    Flohr, Thomas
    Schrappe, Martin
    Ludwig, Wolf-Dieter
    Tolle, Gabriele
    Happich, Margit
    Muckenthaler, Martina U.
    Kulozik, Andreas E.
    [J]. BLOOD, 2006, 108 (04) : 1151 - 1157
  • [5] Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia
    De Keersmaecker, Kim
    Atak, Zeynep Kalender
    Li, Ning
    Vicente, Carmen
    Patchett, Stephanie
    Girardi, Tiziana
    Gianfelici, Valentina
    Geerdens, Ellen
    Clappier, Emmanuelle
    Porcu, Michael
    Lahortiga, Idoya
    Luca, Rossella
    Yan, Jiekun
    Hulselmans, Gert
    Vranckx, Hilde
    Vandepoel, Roel
    Sweron, Bram
    Jacobs, Kris
    Mentens, Nicole
    Wlodarska, Iwona
    Cauwelier, Barbara
    Cloos, Jacqueline
    Soulier, Jean
    Uyttebroeck, Anne
    Bagni, Claudia
    Hassan, Bassem A.
    Vandenberghe, Peter
    Johnson, Arlen W.
    Aerts, Stein
    Cools, Jan
    [J]. NATURE GENETICS, 2013, 45 (02) : 186 - 190
  • [6] Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
    Flex, Elisabetta
    Petrangeli, Valentina
    Stella, Lorenzo
    Chiaretti, Sabina
    Hornakova, Tekla
    Knoops, Laurent
    Ariola, Cristina
    Fodale, Valentina
    Clappier, Emmanuelle
    Paoloni, Francesca
    Martinelli, Simone
    Fragale, Alessandra
    Sanchez, Massimo
    Tavolaro, Simona
    Messina, Monica
    Cazzaniga, Giovanni
    Camera, Andrea
    Pizzolo, Giovanni
    Tornesello, Assunta
    Vignetti, Marco
    Battistini, Angela
    Cave, Helene
    Gelb, Bruce D.
    Renauld, Jean-Christophe
    Biondi, Andrea
    Constantinescu, Stefan N.
    Foa, Robin
    Tartaglia, Marco
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (04) : 751 - 758
  • [7] Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B
    Hennighausen, Lothar
    Robinson, Gertraud W.
    [J]. GENES & DEVELOPMENT, 2008, 22 (06) : 711 - 721
  • [8] Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
    Kleppe, Maria
    Lahortiga, Idoya
    El Chaar, Tiama
    De Keersmaecker, Kim
    Mentens, Nicole
    Graux, Carlos
    Van Roosbroeck, Katrien
    Ferrando, Adolfo A.
    Langerak, Anton W.
    Meijerink, Jules P. P.
    Sigaux, Francois
    Haferlach, Torsten
    Wlodarska, Iwona
    Vandenberghe, Peter
    Soulier, Jean
    Cools, Jan
    [J]. NATURE GENETICS, 2010, 42 (06) : 530 - U84
  • [9] Kontro M, 2014, LEUKEMIA
  • [10] The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function
    Kox, C.
    Zimmermann, M.
    Stanulla, M.
    Leible, S.
    Schrappe, M.
    Ludwig, W-D
    Koehler, R.
    Tolle, G.
    Bandapalli, O. R.
    Breit, S.
    Muckenthaler, M. U.
    Kulozik, A. E.
    [J]. LEUKEMIA, 2010, 24 (12) : 2005 - 2013